Deciphering the enzymatic target of a new family of antischistosomal agents bearing a quinazoline scaffold using complementary computational tools

References

• Colley DG, Bustinduy AL, Secor WE, King CH. Human schistosomiasis. Lancet 2014;383:2253–64.
   PubMed Web of Science ®Google Scholar
• Boissier J, Grech-Angelini S, Webster BL, et al. Outbreak of urogenital schistosomiasis in corsica (france): an epidemiological case study. Lancet Infect Dis 2016;16:971–9.
   PubMed Web of Science ®Google Scholar
• Mutapi F, Maizels R, Fenwick A, Woolhouse M. Human schistosomiasis in the post mass drug administration era. Lancet Infect Dis 2017;17:e42–8.
   PubMed Web of Science ®Google Scholar
• Aruleba RT, Adekiya TA, Oyinloye BE, et al. PZQ therapy: how close are we in the development of effective alternative anti-schistosomal drugs? Infect Disord Drug Targets 2019;19:337–49.
   PubMedGoogle Scholar
• Cioli D, Pica-Mattoccia L, Basso A, Guidi A. Schistosomiasis control: praziquantel forever? Mol Biochem Parasitol 2014;195:23–9.
   PubMed Web of Science ®Google Scholar
• Thetiot-Laurent SA, Boissier J, Robert A, Meunier B. Schistosomiasis chemotherapy. Angew Chem Int Ed Engl 2013;52:7936–56.
   PubMed Web of Science ®Google Scholar
• Ferreira LG, Oliva G, Andricopulo AD. Target-based molecular modeling strategies for schistosomiasis drug discovery. Future Med Chem 2015;7:753–64.
   PubMed Web of Science ®Google Scholar
• Gilbert IH. Drug discovery for neglected diseases: molecular target-based and phenotypic approaches. J Med Chem 2013;56:7719–26.
   PubMed Web of Science ®Google Scholar
• Heilker R, Lessel U, Bischoff D. The power of combining phenotypic and target-focused drug discovery. Drug Discov Today 2019;24:526–32.
   PubMed Web of Science ®Google Scholar
• Sydow D, Burggraaff L, Szengel A, et al. Advances and challenges in computational target prediction. J Chem Inf Model 2019;59:1728–42.
   PubMed Web of Science ®Google Scholar
• Gaulton A, Hersey A, Nowotka M, et al. The ChEMBL database in 2017. Nucleic Acids Res 2017;45:D945–4.
   PubMed Web of Science ®Google Scholar
• Kim S, Chen J, Cheng T, et al. PubChem 2019 update: improved access to chemical data. Nucleic Acids Res 2019;47:D1102–D1109.
   PubMed Web of Science ®Google Scholar
• Lounkine E, Keiser MJ, Whitebread S, et al. Large-scale prediction and testing of drug activity on side-effect targets. Nature 2012;486:361–7.
   PubMed Web of Science ®Google Scholar
• Botros SS, William S, Sabra AA, et al. Screening of a PDE-focused library identifies imidazoles with in vitro and in vivo antischistosomal activity. Int J Parasitol Drugs Drug Resist 2019;9:35–43.
   PubMed Web of Science ®Google Scholar
• Martinez A, Gil C, Castro A, et al. Benzothiadiazine dioxide human cytomegalovirus inhibitors: synthesis and antiviral evaluation of main heterocycle modified derivatives. Antivir Chem Chemother 2003;14:107–14.
   PubMedGoogle Scholar
• Liang YS, Bruce JI, Boyd DA. Laboratory cultivation of schistosome vector snails and maintenance of schistosome life cycles. Proc First Sino-Am Sym 1987;1:34–48.
   Google Scholar
• Duvall RH, DeWitt WB. An improved perfusion technique for recovering adult schistosomes from laboratory animals. Am J Trop Med Hyg 1967;16:483–6.
   PubMed Web of Science ®Google Scholar
• Cheever AW. Conditions affecting the accuracy of potassium hydroxide digestion techniques for counting Schistosoma mansoni eggs in tissues. Bull World Health Organ 1968;39:328–31.
   PubMedGoogle Scholar
• Pellegrino J, Oliveira CA, Faria J, Cunha AS. New approach to the screening of drugs in experimental schistosomiasis mansoni in mice. Am J Trop Med Hyg 1962;11:201–15.
   PubMed Web of Science ®Google Scholar
• Pica-Mattoccia L, Cioli D. Sex- and stage-related sensitivity of Schistosoma mansoni to in vivo and in vitro praziquantel treatment. Int J Parasitol 2004;34:527–33.
   PubMed Web of Science ®Google Scholar
• Botros S, Pica-Mattoccia L, William S, et al. Effect of praziquantel on the immature stages of Schistosoma haematobium. Int J Parasitol 2005;35:1453–7.
   PubMed Web of Science ®Google Scholar
• Rydberg P, Gloriam DE, Olsen L. The smartcyp cytochrome p450 metabolism prediction server. Bioinformatics 2010;26:2988–9.
   PubMed Web of Science ®Google Scholar
• Awale M, Reymond JL. The polypharmacology browser: a web-based multi-fingerprint target prediction tool using chembl bioactivity data. J Cheminform 2017;9:11.
   PubMed Web of Science ®Google Scholar
• Wang Z, Liang L, Yin Z, Lin J. Improving chemical similarity ensemble approach in target prediction. J Cheminform 2016;8:20.
   PubMed Web of Science ®Google Scholar
• Keiser MJ, Roth BL, Armbruster BN, et al. Relating protein pharmacology by ligand chemistry. Nat Biotechnol 2007;25:197–206.
   PubMed Web of Science ®Google Scholar
• Waterhouse A, Bertoni M, Bienert S, et al. Swiss-model: homology modelling of protein structures and complexes. Nucleic Acids Res 2018;46:W296–303.
   PubMed Web of Science ®Google Scholar
• UniProt C. Uniprot: a worldwide hub of protein knowledge. Nucleic Acids Res 2019;47:D506–15.
   PubMed Web of Science ®Google Scholar
• Lovell SC, Davis IW, Arendall WB, 3rd, et al. Structure validation by Cα geometry: ϕ,ψ and Cβ deviation. Proteins 2003;50:437–50.
   PubMed Web of Science ®Google Scholar
• Wiederstein M, Sippl MJ. ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res 2007;35:W407–10.
   PubMed Web of Science ®Google Scholar
• Colovos C, Yeates TO. Verification of protein structures: patterns of nonbonded atomic interactions. Protein Sci 1993;2:1511–9.
   PubMed Web of Science ®Google Scholar
• Eisenberg D, Luthy R, Bowie JU. VERIFY3D: assessment of protein models with three-dimensional profiles. Meth Enzymol 1997;277:396–404.
   PubMed Web of Science ®Google Scholar
•  Schrödinger Release 2015-4: Ligprep, Schrödinger, LLC, New York, NY, 2015.
   Google Scholar
• Jorgensen WL, Maxwell DS, Tirado-Rives J. Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. J Am Chem Soc 1996;118:11225–36.
   Web of Science ®Google Scholar
• Banks JL, Beard HS, Cao Y, et al. Integrated modeling program, applied chemical theory (IMPACT). J Comput Chem 2005;26:1752–80.
   PubMed Web of Science ®Google Scholar
• Sastry GM, Adzhigirey M, Day T, et al. Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des 2013;27:221–34.
   PubMed Web of Science ®Google Scholar
•  Schrödinger Suite 2015-4 including Protein Preparation Wizard, Epik, Impact, and Prime, Schrödinger, LLC, New York, NY, 2015.
   Google Scholar
•  Schrödinger Release 2015-4: Maestro, Schrödinger, LLC, New York, NY, 2015.
   Google Scholar
• Morris GM, Goodsell DS, Halliday RS, et al. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comp Chem 1998;19:1639–62.
   Web of Science ®Google Scholar
• Morris GM, Huey R, Lindstrom W, et al. Autodock4 and Autodocktools4: automated docking with selective receptor flexibility. J Comput Chem 2009;30:2785–91.
   PubMed Web of Science ®Google Scholar
• Sherman W, Day T, Jacobson MP, et al. Novel procedure for modeling ligand/receptor induced fit effects. J Med Chem 2006;49:534–53.
   PubMed Web of Science ®Google Scholar
• Friesner RA, Murphy RB, Repasky MP, et al. Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem 2006;49:6177–96.
   PubMed Web of Science ®Google Scholar
• Jacobson MP, Friesner RA, Xiang Z, Honig B. On the role of the crystal environment in determining protein side-chain conformations. J Mol Biol 2002;320:597–608.
   PubMed Web of Science ®Google Scholar
• Watanabe A, Mayumi K, Nishimura K, Osaki H. In vivo use of the cyp inhibitor 1-aminobenzotriazole to increase long-term exposure in mice. Biopharm Drug Dispos 2016;37:373–8.
   PubMed Web of Science ®Google Scholar
• Berman HM, Battistuz T, Bhat TN, et al. The protein data bank. Acta Crystallogr D Biol Crystallogr 2002;58:899–907.
   PubMed Web of Science ®Google Scholar
• Kinoshita T, Miyake H, Fujii T, et al. The structure of human recombinant aldose reductase complexed with the potent inhibitor zenarestat. Acta Crystallogr D Biol Crystallogr 2002;58:622–6.
   PubMed Web of Science ®Google Scholar
• Liu J, Dyer DH, Cheng J, et al. Aldose reductase from Schistosoma japonicum: crystallization and structure-based inhibitor screening for discovering antischistosomal lead compounds. Parasit Vectors 2013;6:162.
   PubMed Web of Science ®Google Scholar
• Luthy R, Bowie JU, Eisenberg D. Assessment of protein models with three-dimensional profiles. Nature 1992;356:83–5.
   PubMed Web of Science ®Google Scholar
• Spycher SE, Tabataba-Vakili S, O’Donnell VB, et al. Aldose reductase induction: a novel response to oxidative stress of smooth muscle cells. FASEB J 1997;11:181–8.
   PubMed Web of Science ®Google Scholar
• Srivastava SK, Yadav UC, Reddy AB, et al. Aldose reductase inhibition suppresses oxidative stress-induced inflammatory disorders. Chem Biol Interact 2011;191:330–8.
   PubMed Web of Science ®Google Scholar
• Alger HM, Williams DL. The disulfide redox system of Schistosoma mansoni and the importance of a multifunctional enzyme, thioredoxin glutathione reductase. Mol Biochem Parasitol 2002;121:129–39.
   PubMed Web of Science ®Google Scholar
• Kuntz AN, Davioud-Charvet E, Sayed AA, et al. Thioredoxin glutathione reductase from Schistosoma mansoni: an essential parasite enzyme and a key drug target. PLoS Med 2007;4:e206.
   PubMed Web of Science ®Google Scholar
• Sayed AA, Cook SK, Williams DL. Redox balance mechanisms in Schistosoma mansoni rely on peroxiredoxins and albumin and implicate peroxiredoxins as novel drug targets. J Biol Chem 2006;281:17001–10.
   PubMed Web of Science ®Google Scholar
• Song L, Li J, Xie S, et al. Thioredoxin glutathione reductase as a novel drug target: evidence from Schistosoma japonicum. PLoS One 2012;7:e31456.
   PubMed Web of Science ®Google Scholar
• Liu J, Wang J, Wang S, et al. Molecular cloning and characterization of Schistosoma japonicum aldose reductase. Parasitol Res 2013;112:549–58.
   PubMed Web of Science ®Google Scholar